8037 Share Price

Open 0.46 Change Price %
High 0.48 1 Day 0.02 4.35
Low 0.46 1 Week 0.07 17.07
Close 0.48 1 Month 0.16 50.00
Volume 11714000 1 Year 0.38 380.00
52 Week High 0.65
52 Week Low 0.10
8037 Important Levels
Resistance 2 0.50
Resistance 1 0.49
Pivot 0.47
Support 1 0.47
Support 2 0.46
HKG HongKong Most Active Stocks
0997 0.06 0.00%
0136 0.21 5.00%
0061 0.04 33.33%
0364 0.03 0.00%
3988 4.01 1.52%
0566 3.91 0.00%
0939 6.35 0.00%
8272 0.04 0.00%
1398 5.11 0.99%
1141 0.24 9.09%
More..
HKG HongKong Top Gainers Stocks
2266 2.74 42.71%
0061 0.04 33.33%
0139 0.18 20.00%
8143 0.30 20.00%
0521 0.37 19.35%
8282 1.20 17.65%
0891 0.68 17.24%
1808 1.13 13.00%
0379 0.10 11.11%
8089 0.20 11.11%
More..
HKG HongKong Top Losers Stocks
4333 60.00 -25.00%
0648 0.04 -20.00%
8340 0.47 -18.97%
8002 4.00 -15.97%
0309 0.32 -15.79%
1063 0.06 -14.29%
0362 0.07 -12.50%
0231 0.08 -11.11%
0149 0.54 -10.00%
8080 0.09 -10.00%
More..

Longlife Group Holdings Ltd. (HKG: 8037)

8037 Technical Analysis 5
As on 20th Feb 2017 8037 Share Price closed @ 0.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.26 & Strong Buy for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
8037 Target for February
1st Target up-side 0.37
2nd Target up-side 0.4
3rd Target up-side 0.44
1st Target down-side 0.27
2nd Target down-side 0.24
3rd Target down-side 0.2
8037 Other Details
Segment EQ
Market Capital 0.00
Sector Consumer Goods
Industry Personal Products
Offical website http://www.longlifechina.com
8037 Address
8037
Vanta Industrial Centre
3rd Floor
Kwai Chung,
Hong Kong
8037 Latest News
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular ...   Dove Medical Press   - 21st Nov 16
United States Nimodipine Market Professional Survey, Growth, Size, Shares ...   Satellite PR News (press release)   - 09th Sep 16
Hong Kong based Pharmaceutical Group linked to AVFC takeover   7500 To Holte (blog)   - 12th May 16
Hong Kong-listed Chinese firm 'set to buy Aston Villa'– report   South China Morning Post   - 12th May 16
Acucela Secures Option to Exclusively License Novel Cataract Treatment   Business Wire (press release)   - 17th Mar 16
Stem Cells Regenerate Human Lens After Cataract Surgery, Restoring Vision   UCSD Medical Center   - 09th Mar 16
Vision Value shares up in Hong Kong, Rui Kang slumps on rights issue   South China Morning Post (subscription)   - 12th Jun 15
Asia Regulatory Roundup: Clinical Trials in Focus in China, India (2 December ...   Regulatory Focus   - 03rd Dec 14
China drafts policy on emergency Ebola diagnosis, approves products   Reuters   - 28th Nov 14
Detecting Fetal Chromosomal Defects Without Risk   UCSD Medical Center   - 06th May 14
Interactive Technical Analysis Chart Longlife Group Holdings Ltd. ( 8037 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Longlife Group Holdings Ltd.
8037 Business Profile
Longlife Group Holdings Limited, an investment holding company, engages in the manufacture, research and development, and distribution of consumer cosmetic, health related products, and capsules products in the People’s Republic of China. The company also manufactures and sells health supplement wine, dental materials and equipment, and household commodities. In addition, it is involved in the trading of household commodities and health related products; and securities in Hong Kong. Longlife Group Holdings Limited was incorporated in 2003 and is based in Kwai Chung, Hong Kong.